FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014661605> ?p ?o ?g. }

• W2014661605 endingPage "198" @default.
• W2014661605 startingPage "191" @default.
• W2014661605 abstract "Ninety-three patients with head and neck cancer were treated with combined cisplatin-peplomycin chemotherapy (CP therapy). Cisplatin (CDDP) 50 mg/m2 i.v. (intravenous) or La. (intraarterial) over 2 hr was given with hydration and mannitol diuresis on day 1. From day 2 through day 6, peplomycin (PEP) 5 mg/day was administered by 5-hr i.v. or La. infusion, or 24-hr continuous hypodermic injection. Of 85 who were evaluable, there were 22 complete responses or CR (26 %) and 36 partial responses or PR (42 %), with an overall response rate of 68 %. Concerning of the route of administration, La. infusion obtained the higher CR and overall response rates than i.v. infusion. Effectiveness was clearly greater in previously untreated cases than in cases that had received some previous therapeutic modality. Looking at response in relation to the number of the courses, at least 2 courses of CP therapy are required. Side effects were recognized in 68 out of 87 evaluable cases (78 %). Nausea and vomiting were the most common (62 %). Renal toxicity was observed in 24 % and was mostly transient. From the above results, it is considered that the CP therapy is effective, not only for the palliative treatment of advanced and recurrent cancer of the head and neck, but also as neo-adjuvant chemotherapy of stage III and IV cases. Ninety-three patients with head and neck cancer were treated with combined cisplatin-peplomycin chemotherapy (CP therapy). Cisplatin (CDDP) 50 mg/m2 i.v. (intravenous) or La. (intraarterial) over 2 hr was given with hydration and mannitol diuresis on day 1. From day 2 through day 6, peplomycin (PEP) 5 mg/day was administered by 5-hr i.v. or La. infusion, or 24-hr continuous hypodermic injection. Of 85 who were evaluable, there were 22 complete responses or CR (26 %) and 36 partial responses or PR (42 %), with an overall response rate of 68 %. Concerning of the route of administration, La. infusion obtained the higher CR and overall response rates than i.v. infusion. Effectiveness was clearly greater in previously untreated cases than in cases that had received some previous therapeutic modality. Looking at response in relation to the number of the courses, at least 2 courses of CP therapy are required. Side effects were recognized in 68 out of 87 evaluable cases (78 %). Nausea and vomiting were the most common (62 %). Renal toxicity was observed in 24 % and was mostly transient. From the above results, it is considered that the CP therapy is effective, not only for the palliative treatment of advanced and recurrent cancer of the head and neck, but also as neo-adjuvant chemotherapy of stage III and IV cases." @default.
• W2014661605 created "2016-06-24" @default.
• W2014661605 creator A5000279891 @default.
• W2014661605 creator A5019581318 @default.
• W2014661605 creator A5046909074 @default.
• W2014661605 creator A5061913181 @default.
• W2014661605 creator A5062434148 @default.
• W2014661605 creator A5076120482 @default.
• W2014661605 creator A5079260748 @default.
• W2014661605 date "1986-01-01" @default.
• W2014661605 modified "2023-09-25" @default.
• W2014661605 title "Combination Chemotherapy With Cisplatin and Peplomycin in Squamous Cell Carcinoma of the Head and Neck" @default.
• W2014661605 cites W2026191692 @default.
• W2014661605 cites W2033449420 @default.
• W2014661605 cites W2036407895 @default.
• W2014661605 cites W2059945676 @default.
• W2014661605 doi "https://doi.org/10.1016/s0385-8146(86)80015-3" @default.
• W2014661605 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2439061" @default.
• W2014661605 hasPublicationYear "1986" @default.
• W2014661605 type Work @default.
• W2014661605 sameAs 2014661605 @default.
• W2014661605 citedByCount "13" @default.
• W2014661605 countsByYear W20146616052013 @default.
• W2014661605 countsByYear W20146616052016 @default.
• W2014661605 countsByYear W20146616052020 @default.
• W2014661605 crossrefType "journal-article" @default.
• W2014661605 hasAuthorship W2014661605A5000279891 @default.
• W2014661605 hasAuthorship W2014661605A5019581318 @default.
• W2014661605 hasAuthorship W2014661605A5046909074 @default.
• W2014661605 hasAuthorship W2014661605A5061913181 @default.
• W2014661605 hasAuthorship W2014661605A5062434148 @default.
• W2014661605 hasAuthorship W2014661605A5076120482 @default.
• W2014661605 hasAuthorship W2014661605A5079260748 @default.
• W2014661605 hasConcept C121608353 @default.
• W2014661605 hasConcept C126322002 @default.
• W2014661605 hasConcept C126894567 @default.
• W2014661605 hasConcept C141071460 @default.
• W2014661605 hasConcept C2776530083 @default.
• W2014661605 hasConcept C2776694085 @default.
• W2014661605 hasConcept C2778239845 @default.
• W2014661605 hasConcept C2780580376 @default.
• W2014661605 hasConcept C2780852908 @default.
• W2014661605 hasConcept C3019864225 @default.
• W2014661605 hasConcept C71924100 @default.
• W2014661605 hasConceptScore W2014661605C121608353 @default.
• W2014661605 hasConceptScore W2014661605C126322002 @default.
• W2014661605 hasConceptScore W2014661605C126894567 @default.
• W2014661605 hasConceptScore W2014661605C141071460 @default.
• W2014661605 hasConceptScore W2014661605C2776530083 @default.
• W2014661605 hasConceptScore W2014661605C2776694085 @default.
• W2014661605 hasConceptScore W2014661605C2778239845 @default.
• W2014661605 hasConceptScore W2014661605C2780580376 @default.
• W2014661605 hasConceptScore W2014661605C2780852908 @default.
• W2014661605 hasConceptScore W2014661605C3019864225 @default.
• W2014661605 hasConceptScore W2014661605C71924100 @default.
• W2014661605 hasIssue "3" @default.
• W2014661605 hasLocation W20146616051 @default.
• W2014661605 hasLocation W20146616052 @default.
• W2014661605 hasOpenAccess W2014661605 @default.
• W2014661605 hasPrimaryLocation W20146616051 @default.
• W2014661605 hasRelatedWork W225421833 @default.
• W2014661605 hasRelatedWork W2328514703 @default.
• W2014661605 hasRelatedWork W2350418051 @default.
• W2014661605 hasRelatedWork W2355640969 @default.
• W2014661605 hasRelatedWork W2372662666 @default.
• W2014661605 hasRelatedWork W2412619742 @default.
• W2014661605 hasRelatedWork W2418644999 @default.
• W2014661605 hasRelatedWork W2461578584 @default.
• W2014661605 hasRelatedWork W3149628602 @default.
• W2014661605 hasRelatedWork W57680343 @default.
• W2014661605 hasVolume "13" @default.
• W2014661605 isParatext "false" @default.
• W2014661605 isRetracted "false" @default.
• W2014661605 magId "2014661605" @default.
• W2014661605 workType "article" @default.